Cryoablation of lung metastases – pro
The ECLIPSE trial enrolled 40 patients with 60 lung metastases treated during 48 cryoablation sessions, with currently a minimum of 12 months of follow-up. Patients were enrolled according to the following key inclusion criteria: 1 to 5 metastases from extrapulmonary cancers, with a maximal diameter of 3.5 cm. It concluded that Cryoablation is a safe and effective treatment for pulmonary metastases with preserved quality of life following intervention,
Thierry de Baere et al, Evaluating Cryoablation of Metastatic Lung Tumors in
PatientsSafety and Efficacy The ECLIPSE TrialInterim Analysis at 1 Year, J Thorac Oncol. 2015;10: 14681474
Philippe L. Pereira, Masala Salvatore, Standards of Practice: Guidelines for Thermal Ablation
of Primary and Secondary Lung Tumors. Cardiovasc Intervent Radiol (2012) 35:247–254